Delaware Gov Matt Meyer Positions State As India Partner In Biomanufacturing, Clean Energy

Photo: Gov Matt Meyer also met with External Affairs Minister S.Jaishankar

India-West News Desk

NEW DELHI — Delaware Governor Matt Meyer on March 2 pitched his state as a key US partner for India in advanced biomanufacturing and innovation, as he met Union Science and Technology Minister Dr. Jitendra Singh at Seva Teerth, here.

Leading a visiting delegation from Delaware, Meyer held talks focused on expanding collaboration in pharmaceuticals, biotechnology, clean energy and innovation led industrial growth. The discussions explored the possibility of building a structured India Delaware partnership, including the creation of a small working group to translate dialogue into concrete projects in research, manufacturing and startup ecosystems.

Meyer described Delaware as a state with a long standing science and industrial heritage, highlighting its strong biopharmaceutical manufacturing base, expanding port infrastructure and business friendly environment. He pointed to Delaware’s established bioscience ecosystem and proximity to major US pharmaceutical companies as advantages that could complement India’s scale and manufacturing capabilities.

Central to the conversation was the role of the National Institute for Innovation in Manufacturing Bio-pharmaceuticals, a Delaware based institute focused on advancing biopharmaceutical manufacturing technologies. Meyer and members of his delegation discussed potential collaboration in advanced biomanufacturing, artificial intelligence enabled production processes, rapid scale up technologies and next generation biologics and vaccines.

The delegation, which included representatives from government, universities and industry, also examined opportunities in clean hydrogen, workforce development, startup incubation and corporate incorporation frameworks. Delaware’s growing innovation ecosystem and regulatory experience were presented as strengths that could support joint research, co development and commercialization initiatives with Indian partners.

Indian officials outlined the country’s expanding biotechnology and pharmaceutical footprint, anchored in part by the Council of Scientific and Industrial Research, which oversees 37 laboratories and thousands of scientists working across industrial research domains. India’s integrated innovation architecture linking government, academia, industry and startups was highlighted as a foundation for deeper state level engagement.

During the interaction, both sides discussed specific areas of cooperation such as joint advanced biomanufacturing platforms, translational research bridges between Indian institutions and Delaware research centers, startup and incubation linkages, and co training in good manufacturing practices, regulatory science and quality systems. Strengthening regulatory science collaboration, aligning standards and building resilient supply chains for critical biopharmaceutical inputs were also identified as priorities.